Stocks and Investing Stocks and Investing
Thu, November 10, 2022

Andrew Berens Maintained (BGNE) at Buy with Increased Target to $210 on, Nov 10th, 2022


Published on 2024-10-28 00:04:16 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "BeiGene, Ltd." (BGNE) at Buy with Increased Target from $200 to $210 on, Nov 10th, 2022.

Andrew has made no other calls on BGNE in the last 4 months.



There are 3 other peers that have a rating on BGNE. Out of the 3 peers that are also analyzing BGNE, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $295 on, Thursday, October 13th, 2022
  • Michael Schmidt of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $205 on, Thursday, October 13th, 2022
  • Xiling Chen of "JP Morgan" Initiated at Buy and Held Target at $296 on, Tuesday, August 9th, 2022

Contributing Sources